3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Opioid Withdrawal: new trials by email Literature Review of Opioid Withdrawal trials Research Report on Opioid Withdrawal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lofexidine for Adults Undergoing Lumbar Spine Surgery Lofexidine Oral Tablet - Opioid Withdrawal | Phase 4 | Completed | Mayo Clinic | 6 | 2019-09-01 | 2022-02-23 |
| Pregabalin for Opiate Withdrawal Syndrome Pregabalin, Clonidine, Doxylamin - Opioid Withdrawal | Phase 4 | Completed | St. Petersburg Bekhterev Research Psychoneurological Institute | 100 | 2014-01-01 | 2020-04-07 |
| Buprenorphine in the Emergency Department Buprenorphine, Clonidine - Opioid Withdrawal, Opioid-use Disorder | Phase 4 | Completed | St. Joseph's Health Centre Toronto | 26 | 2013-03-01 | 2017-06-02 |
Emergencies (1) · Opioid-Related Disorders (1)
Chemically-Induced Disorders (1) · Disease Attributes (1) · Mental Disorders (1) · Narcotic-Related Disorders (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Substance-Related Disorders (1)
Clonidine (2) · Benzodiazepines (1) · Buprenorphine (1) · Ketorolac (1) · Loperamide (1) · Metoclopramide (1) · Pregabalin (1) · lofexidine (1) · phenazepam (1)
Mayo Clinic (1) · St. Joseph's Health Centre Toronto (1) · St. Petersburg Bekhterev Research Psychoneurological Institute (1)
Russia (1) · United States (1)
Anita Srivastava, MD (1) · William M Hooten, MD (1)